Neapharma
ActiveSummary
Neapharma has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €112,022 and a net result of -€5,946. Equity is growing by about 21% per year across the filed financial years. Its solvency ranks better than 65% of 22,576 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
25-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
07-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 7 days late
2023
31-12
Financial
Equity above €100,000equity €108,725 ▲41.5%
4 profitable years in a row build equity to €108,725.
05-12
Gazette deed
Resignations: Kristof De Kegel, Kjell De Potter and Olivier Van BaeveghemAppointments: Kristof De Kegel, Kjell De Potter and Olivier Van Baeveghem · Amendment of the articles · Capital conversion17 facts ▸
Gazette deed
Resignations: Kristof De Kegel, Kjell De Potter and Olivier Van Baeveghem
Appointments: Kristof De Kegel, Kjell De Potter and Olivier Van Baeveghem · Amendment of the articles · Capital conversion17 facts ▸
- General meeting, 30-11-2023
- Amendment of the articles (2 times)
- Capital conversion, EUR, “eigen vermogensrekening “niet-opgevraagde inbrengen”” (deed in Dutch)
- Reserve release, “opheffen statutair onbeschikbare eigen vermogensrekening, middelen beschikbaar voor uitkering” (deed in Dutch)
- Other provision, “aanwending jaarlijkse nettowinst bepaald door algemene vergadering op voorstel bestuursorgaan, elk aandeel gelijk aandeel, winstbestemming en interim-dividend” (deed in Dutch)
- Capital
- Other provision, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Director resignation, Kristof De Kegel (manager)
- Director appointment, Kristof De Kegel (director (not named in the articles))
- Director resignation, Kjell De Potter (manager)
- Director appointment, Kjell De Potter (director (not named in the articles))
- Director resignation, Olivier Van Baeveghem (manager)
- +5 further facts in this act
28-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
01-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 1 day late
2021
25-06
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial
Back to profitnet €47,456
Net result €47,456 after one loss-making year.
31-08
NBB filing
Annual accounts filed
financial year 2019 · micro format · 31 days late
2019
31-12
Financial
Weakest financial yearnet -€37,189
Net result drops to -€37,189, the lowest in the series; recovery starts the following year.
02-08
NBB filing
Annual accounts filed
financial year 2018 · micro format · 2 days late
2018
17-08
NBB filing
Annual accounts filed
financial year 2017 · micro format · 17 days late
2017
07-08
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format · 7 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 4 deeds read
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.